The Pharmaceutical industry is one of the world’s largest industries, grossing well over $300 billion in the United States alone. Understanding how the drugs the pharma industry develops work and different characteristics of these compounds is important to nearly everyone as 50% of the US population takes at least one prescription medication regularly and nearly everyone takes a pharmaceutical pill at some point in their life.[1] The following is a growing list of pharmaceutical compounds organized by disorder.
See Pharmaceutical Drug Targets for a list of drug targets organized by disease.
Treatments
The following is a list of FDA Approved treatments for various diseases, organized by disorder. Each entry highlights general information about the therapeutic, pharmacokinetic data comparisons within its drug class, and a structural analysis explaining how the drug compound functions in vivo.
|
|
|
Antagonists at glutamatergic NMDA receptors
|
|
|
See Treatment of multiple myeloma
Anti-prostate cancer
Anti-myeloma
Anti-acute lymphocytic leukemia
Anti-non-small cell lung cacinoma
B-Raf Kinase Inhibitor
- Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032)
Chemotherapy
Estrogen Receptor Modulator
mTOR inhibitor
- Rapamune - Generic: Sirolimus (Rapamycin)
- Afinitor - Generic: Everolimus
- Torisel - Generic: Temsirolimus
Multiple Receptor Tyrosine kinase (VEGFR, PDGFR, EGFR, KIT, Abl, RAF kinase) Inhibitors
See Treatment of chronic myelogenous leukemia, Treatment of hepatocellular carcinoma, Treatment of renal cell carcinoma, Treatment of gastrointestinal stromal tumor, VEGFR inhibitors and Tyrosine-kinase inhibitors.
Poly ADP ribose polymerase (PARP) inhibitors
See also Anti-cancer drugs, Anticancer drugs and RAF kinase inhibitors
|
|
|
Erectile Dysfunction
|
|
Mechanism is not completely understood
Inhibitors of the sodium glucose co-transporter-2 (SGLT-2)
|
|
Phosphodiesterase Type 5 Inhibitor
- Cialis - Generic: Tadalafil
- Levitra - Generic: Vardenafil
- Viagra - Generic: Sildenafil
|
|
Niemann-Pick C1-like 1 (NPC1L1) protein blocker
|
|
|
|
|
Inhibitors of neprilysin
Renin inhibitors
Angiotensin II receptor antagonist
|
|
Chemokine Receptor Type 5 (CCR5) Inhibitors
- Selzentry - Generic: Maraviroc
- Baraclude - Generic: Entecavir
- Emtriva - Generic: Emtricitabine
- Epivir - Generic: Lamivudine
- Hivid - Generic: Zalcitabine
- Retrovir - Generic: Zidovudine
- Videx - Generic: Didanosine
- Viread - Generic: Tenofovir
- Zerit - Generic: Stavudine
- Ziagen - Generic: Abacavir
Cytochrome P450 inhibitors
Combinations
|
|
- Voltaren - Generic: Diclofenac also may inhibit phospholipase A2 as part of its mechanism of action.
|
|
|
--
|
--
|
|
|
|
Coming Soon...
Tamoxifen
Cozaar
Januvia
Azithromycin
Puromycin
Tamiflu
Relenza
Teleprevir
Rituxan
Arzerra
Gleevec
Taxol
Lipoderm
Paxil
Viagra
Cialis
Celebrex
Vioxx
References